Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. - Wikidata - awgldk - TriplyDB

Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.

Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.

http://www.wikidata.org/entity/Q36548225

about

Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single-and double-stranded DNAs Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees.Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCV Human Immunodeficiency Virus Seroconversion and Evolution of the Hepatitis C Virus Quasispecies Hepatitis C virus infection in san francisco’s HIV-infected urban poor Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population Risk factors for hepatitis C infection among sexually transmitted disease-infected, inner city obstetric patients Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis Spatial access to sterile syringes and the odds of injecting with an unsterile syringe among injectors: a longitudinal multilevel study Drug-related arrest rates and spatial access to syringe exchange programs in New York City health districts: combined effects on the risk of injection-related infections among injectors Guidelines for the assessment and acceptance of potential brain-dead organ donors.A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection.A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users.Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto Rico A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort HIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis.Prevalence and correlates of Hepatitis C among injection drug users: The significance of duration of use, incarceration and race/ethnicity.Risk factors associated with Hepatitis C among female substance users enrolled in community-based HIV prevention studies A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.Screening for hepatitis C virus in human immunodeficiency virus-infected individuals.Epidemiology of hepatitis C virus (HCV) infection.Prevalence and risk factors for hepatitis C virus infection among young Thai men.Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review.Hepatitis C virus infection in the human immunodeficiency virus infected patient.Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan.Changes in blood-borne infection risk among injection drug users.Hepatitis C in HIV-infected individuals: cure and control, right now.Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells Burden of blood transmitted infections in substance users admitted for inpatient treatment in Singapore and the associated factors.Characteristics of HIV-infected women and factors associated with HCV seropositivity in the Republic of Georgia.Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis.Developing and validating a scoring tool for identifying people who inject drugs at increased risk of hepatitis C virus infection.The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action.Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran.

P2860

Q24803011-6712AE41-87D1-4594-9D01-F7BD363415E0 Q27469352-9F02EA0B-FB4B-4282-B2BB-ADB4F47A66E4 Q27469409-31E221F6-A9A7-4414-BD67-FAB599FD2892 Q27469647-A7D709F0-A55A-4B26-A5C1-5AEBE96FCDDC Q27469764-3654EA44-E419-4D63-8A7A-77B388489A39 Q27469782-5545BBB9-8372-4EAB-8363-D280834969D1 Q27473306-B0EC9FBB-1BF8-4D0E-AD65-05A940060573 Q27477954-DA393EB5-06A9-423A-A825-86E4B5404D69 Q27478294-E823047D-8BA1-4A90-BDEB-6F55D20279D4 Q28361460-3561198F-B990-4F6A-A092-62AAE69C867B Q28362291-DB148C08-C8EF-4100-B6FD-3D0610702AE5 Q28710127-D1CA0C86-1BD5-46A8-888E-00130A276D9C Q28732206-C1B75508-FAD4-4EF2-8171-E03D9C7230CF Q30372798-F123B72E-E30D-4483-8056-0E0AD6188AB1 Q31152033-D07CF951-7651-4106-931B-D9BAFBD48C7D Q33256564-95CC4258-C3D5-47B1-948B-A342518CE8D5 Q33262182-54693355-1E3B-4615-9427-91C0449C416C Q33483115-A55A46B8-A915-4F31-BA83-8ED4B9F3B686 Q33707925-937000C2-AE83-4FE1-8016-9A22015559A8 Q33724826-F1A0F219-9E6A-42C3-81B4-BCEF82EE4214 Q33777428-537B2F6D-A4FD-4403-BFE5-104E5BEED1BF Q33840231-6B64A539-62BB-4333-BB66-A4C5E544D6ED Q33872878-22FDC2A7-8CDA-4B8E-B4F9-8BD0BE9A8EA6 Q33906157-D448C98D-8A0D-4FB7-AC3E-EB75F6E3EE72 Q33929089-C62E82D7-C3E0-49AB-86C7-B535C3F21654 Q33965308-EDF212DA-41F5-4F29-A6DB-9C44B26BD0B1 Q33995067-E4340BB6-7B26-4268-B29D-0D48BCD029B7 Q34024930-C1559DEC-C6FA-462C-B382-15F232FDC429 Q34088235-30018CED-8726-44B1-94CB-98484CB0FBC8 Q34168504-9725B0CD-360E-4F9D-9445-A932E349FEC4 Q34507544-7B32E1CB-54FD-4104-A44B-F25A6182680F Q34772870-E93C55C5-C275-48FC-885E-FD7DEE2F0D24 Q35047562-35244879-E966-48D7-8069-D0868F8E4226 Q35077992-34533BD7-FF11-4353-AB5F-04FA18F07C02 Q35150028-28171A26-FFD8-4856-97BF-F12B304FABF3 Q35158311-74BD7112-5C57-4745-B90C-67A6052CBECC Q35197198-F3ADF178-46EB-4560-B661-2F9AF5735ECA Q35659866-368265CE-BD88-48F2-86E6-6E09681E832C Q35742761-ED410B3E-5EC8-4EE6-A013-96EA613AF105 Q35819898-35AC1E91-7FDC-4423-B402-AE490BDAC88A

P2860

Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.

http://www.wikidata.org/entity/Q36548225

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Incidence and risk factors for ...... users in Baltimore, Maryland.

@ast

Incidence and risk factors for ...... users in Baltimore, Maryland.

@en

type

label

Incidence and risk factors for ...... users in Baltimore, Maryland.

@ast

Incidence and risk factors for ...... users in Baltimore, Maryland.

@en

prefLabel

Incidence and risk factors for ...... users in Baltimore, Maryland.

@ast

Incidence and risk factors for ...... users in Baltimore, Maryland.

@en

P1433

Q36548225-2DDE5451-A523-4A08-A1C6-F79CEF2E928F

P1476

Q36548225-2D1600A5-208B-4839-A70B-4FCD99A22335

P2093

Q36548225-496346A5-1F01-4B0E-B2AE-7170E489F3DE

Q36548225-79B2EC9D-02E4-4D6D-AFB1-3D5A7DB979A6

Q36548225-8C52180A-0D5E-4345-BA9C-A8CEBA4DC2BE

Q36548225-978A2BE3-7095-434A-90F8-4849667AFAF3

Q36548225-D92C1C72-E1AC-4223-B873-61637643CDE6

Q36548225-E6F61AE2-5D37-440B-A572-891B740BFD61

P2860

Q36548225-12A1474A-7F38-4EDB-A561-776A1D794FC4

Q36548225-1D3E8A5F-EF87-4214-A493-E9EA63969C85

Q36548225-2C72B673-CFB6-45EA-BCDC-4503772AF79D

Q36548225-5A687016-B7D3-4AE3-AAF8-08B35832BF01

Q36548225-618735DD-18E8-44FA-BA57-867ACD0ADC55

Q36548225-64F8E4F8-B164-4BEC-9945-AA58D76A3A45

Q36548225-690701D3-32FA-4627-BB0A-10CAC21990F5

Q36548225-7FF5010A-33C7-43F7-A7D7-4FD554FB4B0C

Q36548225-89D13FD4-4687-466F-8140-8A2733E51A5F

Q36548225-90232823-DBC1-4F8D-B2A7-9D2BA94DB832

P304

Q36548225-0795C251-6B05-47BA-A987-462CCCFF52A3

P31

Q36548225-D49919C2-2A4B-41B5-85AA-878516CE872E

P407

Q36548225-3483DE8D-377F-4C98-A04C-D62009F194CA

P433

Q36548225-EC912B68-CC1A-4578-805E-2E9BAC9F1CC4

P478

Q36548225-C251809A-4A21-4A95-8869-DEA64794A4ED

P577

Q36548225-9A1C0AF9-838B-4AFF-A477-558D74233D5E

P698

Q36548225-2A278D2A-1B1B-4DFC-96A4-572D8BE3C3B4

P932

Q36548225-8C1596F7-C558-44DF-87DA-C565C58DECE8

P1433

Journal of Clinical Microbiology

P1476

Incidence and risk factors for ...... g users in Baltimore, Maryland

@en

P2093

C M Lyles

http://www.w3.org/2001/XMLSchema#string

D L Thomas

http://www.w3.org/2001/XMLSchema#string

D Vlahov

http://www.w3.org/2001/XMLSchema#string

K E Nelson

http://www.w3.org/2001/XMLSchema#string

S A Villano

http://www.w3.org/2001/XMLSchema#string

S Cohn

http://www.w3.org/2001/XMLSchema#string

P2860

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam.

Epidemiology of hepatitis C in the West.

Hepatitis C virus in the setting of transplantation.

Correlates of hepatitis C virus infections among injection drug users.

A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army.

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.

Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.

Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme.

Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study.

P304

3274-3277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

1997-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9399533

http://www.w3.org/2001/XMLSchema#string

P932

230161

http://www.w3.org/2001/XMLSchema#string